chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client came to clinic and received 4 vaccines. She spoke a foreign language and was accompanied by her brother who also spoke limited English. Per brother, client began to feel ill right after receiving the vaccines. He went into the TB clinic with her to report that she was not well. She was observed to be itching all over; head, neck, hands, arms. She was extremely restless, felt like her heart was pounding, had stomach discomfort and felt short of breath although respirations did not appear labored. Client was seen by a provider, adult EPIPEN was administered, and vitals monitored until arrival of EMS. She was taken to nearby emergency department for further treatment.
Fever of 100 degrees the day after vaccine and had muscle aches and then headaches. On the day after the vaccine, pain and redness/rash in left arm (lymph nodes) 4 inch long by 3 in. Red area has moved around the upper arm to a different spot on the left upper arm over the  past three days. Red area is hot to touch and has not gone away yet.
Day after shot I was cold but sweating, had a headache and severe fatigue. 10/18/21 I missed work because I have all that again AND this awful abdominal pain unlike anything I have ever felt before. Today 10/19/21 it is still here and headache worse.
Box 17 - Shigrix (Dose 1 of 2)   Painful at beginning, but turned into discomfort over the next three days. Discomfort in left arm from shoulder blade to bicep.  Discomfort has lessened, but is still present. Seen by NP, prescribed Ibuprofen. Discomfort is still present.
Approximately 18 hrs after injection of vaccine, client develop initially under skin followed by development of wheals on neck, torso, head and face right side. Later develop throat irritation and tightness. Has been on Benadryl since Saturday night. Remains on 25 mg Benadryl with decreased free of doses each day.
Information has been received from a unspecified pharmacist concerning an over 65 year old male who in December 2009, was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# not reported) subcutaneously. The pharmacist reported that the patient got shingles in December 2010, 1 year after receiving ZOSTAVAX (Merck) therapy. On an unspecified date, the patient had "bloodwork" test and the result was not reported. At the time of reporting, the outcome of shingles was not reported. The patient sought unspecified medical attention. No further information is available.
HPI: she reports symptoms mainly started on Wednesday. She has Sarcoid and is on Imuran. She states she usually has a cough but it became a lot worse the last couple days. She has been vaccinated for Covid.         F/c/sweats, body aches-has had aches x 2 days, +chills, no fever         Cough-dry cough         SOA,CP-no         Sore throat-no         Congestion-slight         Headache-yes         Earache-no         Fatigue-yes         N/V/D-no         Loss of taste or smell-no         Covid exposure-no known Covid exposure but her husband started getting sick with the same symptoms 2 days before she did and he has not been vaccinated         Travel in the last 2 weeks-         Work or school
Pt recv vax & was found to have an elevated GGTP during routine lab work; The remainder of the complete blood cell (CBC), platelet, & diff counts on that day were w/in nl range x/EOS 43;
5mm after VAX HTN BP 160's-170's, fatigue flushing, decreased vision, lightheaded, can't focus vision. Later arthralgias, fatigue. Sx improved after 4 hrs, Resolved after 48hrs. EMT eval recommended ER eval, but pt declined, went home instead.
Administered pediatric dose (0.5ml) of ENGERIX-B Hepatitis B vaccine instead of adult dose.
Narrative: This is a VACCINE FAILURE. Patient received 2 doses of Pfizer covid-19 vaccine, in march and april of 2021, and then was admitted with COVID-19 positive PCR test on 6/21/21.
Patient came to the ED with headache, body aches, and fever.  Patient admitted to the hospital with Covid and treated with remdesivir.
10: 30 am: Patient received Pfizer booster, 0.3 ml IM via (L) deltoid.    10:45 am: Pt reported feeling dizzy. Lung sounds clear to auscultation, respiratory rate 20, unlabored, HR 60. Pt reported taking atenolol after breakfast this morning.   10:55 am: Pt reported feeling nauseated with a dry mouth. Pt gaze unfocused, pt reported feeling like she was "staring through a tunnel." Pt tool a sip of water, denied difficulty breathing.   Nurse assisted patient to a gurney.  11:00 am: Pt reported that her throat was "tight." Began intermittently coughing. Pt attempted to sip water and complained that it was "hard to swallow, like something was blocking" her throat.   Nurse called 911, administered 0.3 epinephrine IM, via (L) anterolateral thigh muscle.   11:10 am: Pt reported that her throat felt less tight, and denied difficulty breathing. Pt reported her vision seemed "better."   11:15 am; Paramedics arrived. Pt with unsteady gait, but ambulated to gurney with assist x 2.
Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Apr2021 at 18:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 04May2021 at 11:00, the patient experienced headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
10 minutes after at healthcare facility elevated heart rate, burning feeling in stomach,  high blood pressure, then again 1 hour after when I got to work, ambulance called and taken to healthcare facility. No more episodes just continued slight elevated heart rate at the moment which I?m working this 6 hours from vaccine.
Suspicion for Vaccine Induced Thrombotic Thrombocytopenia  -Presented to the ER 10/20/2022 and diagnosed with  Bilateral PE w/right heart strain  ? heparin infusion started  -Left ICA CVA on heparin  a few hours later ?occlusion lysed with tenecteplase  and mechanical thrombectomy 10/20/2022 Patient was intubated in the ER  and transferred to the intensive care unit  -Gross Hematuria anticoagulation was held for a period of time while bleeding  -Anticoagulation switched to argatroban and eventually transitioned to warfarin  -extensive DVT ? left lower extremity discovered on imaging  11/3/2022 Of note previous admission to the hospital on 10/16/2022 for Ileus small bowel  Of note previous admission to the hospital for  5 Vessel  CABG 10/7/2022, discharged on 10/12/2022 raising concern for Heparin induced thrombocytopenia ? however testing is not clear between HIT/T or VITT see lab results below
Developed diverticulitis 7 days after vaccination. Low grade fever, diagnosed by CT-scan, treated as outpatient with oral antibiotics. I am not alleging a cause: effect realtionship between the vaccine & development of diverticulitis.  I had a previous sigmoid colectomy in 2018 for diverticulitis.  This was the only flair since surgery in 2018.
I received my first Moderna vaccine on 12/29/19. Day one post vaccine I developed a welt, red, warm , raised about quarter in size for 4 days. It then disappeared and then reappeared on day 7 post vaccine.  It was red, hot, raised, and extremely itchy.  It was larger in size slightly bigger than a half dollar. Today 2 weeks post vaccine it returned. Again itchy, red, warm to touch, raised and much larger in size. I put a call out to the CDC last week and have yet to hear back.
I get all sorts of pain; Fever of 101.3F; Slight shortness of breath; Confusion; Extreme fatigue and weakness.; Extreme fatigue and weakness.; This is a spontaneous report from two contactable consumers (one is the patient).  This 90-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EN6200), via an unknown route in the left arm, on 20Feb2021 at single dose for COVID-19 immunization, administered at Public Health Clinic/(Name) facility. Historical vaccine includes the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9262) as single dose on 30Jan2021 for COVID-19 immunization. No other vaccine was received in four weeks. Relevant medical history included melanoma, lung cancer, peripheral neuropathy, arthritis and heart failure. Past drug history included allergy to penicillin. Relevant concomitant medications included spironolactone and bumetanide. On 22Feb2021, the patient experienced extreme fatigue and weakness, confusion and slight shortness of breath. He had fever of 101.3F five days after second dose of vaccine. The patient stated, 'I get all sorts of pain'. Pre-vaccination and post-vaccination COVID tests were not performed. The patient was not treated for the events. The outcome of the event 'I get all sorts of pain' was unknown while the outcome of the remaining events was not recovered.  No follow-up attempts are needed. No further information is expected.
This case was reported by a physician via sales rep and described the occurrence of swelling arm in a patient who received BEXSERO (batch number unknown, expiry date unknown). On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, the dose was an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced swelling arm. The patient was treated with antibiotics. On an unknown date, the outcome of the swelling arm was recovered/resolved. It was unknown if the reporter considered the swelling arm to be related to BEXSERO. Additional details were reported as follows: The age at vaccination was not reported. The patient experienced swelling in the arm like an abscess for one week and was treated with antibiotics. The patient refused the second dose.
Information has been received from a licensed practical nurse concerning a female patient "in her 40's, with diabetes, hypertension, reflux and an allergy to morphine who on 09-OCR-2006 was vaccinated intramuscularly with a dose of Pneumovax 23 (lot #651401/0619F). Concomitant therapy included DIOVAN, PREVACID, XANAX, BYETTA. Six hours after vaccination the patient experienced severe pain in the vaccinated arm, little redness, muscle stiffness and weakness in the arm, and limited range of motion in the arm. Unspecified medical attention was sought. No lab studies were performed. She was treated with LORTAB and naproxen. At the time of report the patient was recovering. No product quality complaint was involved. Additional information has been requested.
Patient's wife stated that patient had been feeling weak and dizzy prior to administration of vaccine.  During observation patient's wife informed medic that patient was feeling dizzy.  Patient was taken to medic area.  Vital signs as follows 63/49, pulse 112   O2 97%           BS 146.
This spontaneous report as received from a pharmacist refers to a 4 month old male patient. The patient's pertinent medical history was not reported. On 10-JUN-2015, the patient was vaccinated with PEDVAXHIB lot # K009955 (expiration date not provided), 0.5 ml, intramuscular and PENTACEL (dose and route of administration were not provided). No adverse effects were reported. Additional information has been requested.
Immediately after receiving the second vaccine, I had migraines and terribly painful menstrual cramps. The same symptoms have occurred this month during my menstrual cycle.
Rash on chest and bruise on left upper arm approximately 7cm. Faded with a non bruised center.
Patient came into the clinic on 07/13/2021 for a diabetes check.  During assessment, patient stated that her left arm still hurts from having her second COVID vaccine over a month ago.  No redness noted, no swelling, tender to the touch
I received my Moderna Covid vaccine around 7:30am on 12/29/2020. On 1/5/2021 at around 8:30pm, I noticed an itchy, erythematous, wheal just anterior to the injection site in the left deltoid. This evolved into hives in about an 8cm annular region on the left deltoid shortly after. The following day, there was an erythematous macular area on the left deltoid approximately 8cm in diameter consistent with a local injection site reaction. It is still present today on 1/7/2021 but is not worsening. I'm reporting because I am a PA and the lapse in onset of injection site reaction following injection seemed somewhat prolonged (7 days). I have no additional symptoms.
On 10/17/22 I (pharmacist) gave the patient his Fluarix and Moderna bivalent IM in his left deltoid (per his request) spaced at least 1" apart. There is no chance I injected anywhere outside the deltoid. Two days later, the patient states he developed a large bruise in a different area from where I gave the vaccine. I saw the bruise in person. It's a large, dark, unusual, extensive bruise, like nothing I've ever seen, on the underside of his left arm, not anywhere near the deltoid where I gave the vaccine. I did not touch his arm hard enough to cause a contusion of that size. I've never seen a vaccine cause this event, unless the patient has an underlying clotting disorder he doesn't know about, or if he is having a very rare immune thrombocytopenic reaction. I called his PCP Dr. this morning, and her nurse practitioner is having the patient visit her for a PT/INR test. The patient denied being on any blood thinners or bumping his arm at home. I'm reporting this out of caution because he is having to seek a doctor's visit.
I've been in menopause for three years and started spotting once a month after my first round of vaccination in April, 2021. This wasn't that bad; just a nuisance and never lasted more than a few hours. It always occurred every 28 days, just like my period used to occur.  I received a booster shot on November 4, 2021, and today I was surprised to find myself bleeding profusely with large blood clots. No warning, no cramps, just a very intense 'period'.    I've read that the COVID vaccine can cause this and felt I should report it to add my experience to any list you have going on for these kinds of symptoms.
about 230AM-began vomiting, t104-106 adm to hosp due to shots mom advises MD;
Pt reported tingling of left arm that radiated down her arm, pt reports that the left side of her jaw was numb. Pt reported these symptoms resolved that day. Pt has headache and fatigue for two days.
pt recv vax 11APR97 & next morning 12APR97;lt arm was swollen (upper & lower);14APR97 1PM pt returned to office lt arm is swollen;denies heat;no fever no redness;
On day  9 I noticed an oval red rash around injection site.  It was about 3 ? long  by 2? wide? approximately.
Patient may have received bivalent Moderna Covid-19 vaccine for patients age 12 to 17; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient may have received bivalent Moderna Covid-19 vaccine for patients age 12 to 17) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Nov-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient may have received bivalent Moderna Covid-19 vaccine for patients age 12 to 17) and NO ADVERSE EVENT (No adverse event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient may have received bivalent Moderna Covid-19 vaccine for patients age 12 to 17) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Patient may have received bivalent Moderna Covid-19 vaccine for patients age 12 to 17).    No concomitant medications were reported. On 27-JAN-2021,patient received first Moderna Primary Series dose of Lot 011J20A ,expiration date was unknown. On 24-FEB-2021,patient received second Moderna Primary Series dose of Lot number 010A21A on left deltoid. Expiration date was unknown. On 16-NOV-2021,patient received first Moderna Covid-19 booster dose of Lot number 014F21A.Expiration date was unknown. On 27-JUL-2022 ,patient received Second Moderna Covid-19 booster dose of Lot number 055A22A, expiration date was 2-NOV-2022 . Patient did not reported adverse reactions for all doses. No treatment information was provided.
Approximately one week after injection experienced a large rash with swelling and pain at injection sight.  Is still present after 5 days
Onset of swelling of extremity (thigh) within 2 hours of vaccine. (Similar symptoms with 1st/Hib). Infant irritable, appeared uncomfortable. No fever. Treated with TYLENOL/BENADRYL.
soreness in his arm; body pain; muscle aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches). At the time of the report, PAIN IN EXTREMITY (soreness in his arm), PAIN (body pain) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medication details were not reported. The patient declined follow-up.   Reporter did not allow further contact
Lips swelled turned blueish in color, whole body became itchy, broke out in hives went to ER, was given Prednisone and then Benadryl at home, returned to PCP the next morning for a Rx of Prednisone and more Benadryl very mild URI without fever and "felt good". Has had flu vaccine 11 years in a row. Last COVID vax 5/22. No other known allergies or anything else new in the date of incident. Still persistent hives Day 4 with Benadryl and Prednisone. Added Zyrtec and ranitidine Day 2/3/4
Flu vaccine administered on 11/4/15. Reported a reddened knot to the injection site, approx. 9 cm in diameter warm / painful to touch on 11/5/15. Also was reporting headache and nausea. Was seen at Occupational Health on 11/5 and instructed to apply ice and use Ibuprofen and Benadryl as needed. The nausea / headache have improved as of 11/6/15, still has some soreness to the injection site.
Localized swelling. Benadryl 2 doses.  Swelling in left arm.
Patient was observed to have a syncope episode lasting less than a minute after  receiving vaccination. Patient was placed from the chair is was sitting onto the floor and legs elevated. 911 was called patient was oriented X3 and did not want Ems to come. We had patient stayed in pharmacy for about 30 more mins. Patient left pharmacy and described he was feeling okay and had no further adverse reactions. Patient describes that he generally pass out after giving blood or dealing with needles.
pt recv vax;anoxia brain damage;sz activity;severe dehydration probable infarctions of brain w/ atrophy evident on CT Scan;
got the shots and got shingles/Suspected vaccination failure; bad shingles in groin area; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles 5 years ago extremely bad whole way around waist not the whole way halfway).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 6 months after receiving Shingles vaccine and unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK Receipt Date: 28-FEB-2023 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient reported that two years after that he/she got the shot and got shingles 6 months later in groin area bad enough to commit suicide. The patient reported that got the Shingles shots afterwards two of them and guess what he/she got the shingles again just as bad. The patient reported that guess what it did not work. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding laboratory test and time to onset confirming shingles were unknown at the time of reporting. For verbatim bad enough to commit suicide not captured as event as it was expression reported by the patient. Follow-up would not possible as no contact details were available.